Dallas

Dallas, Texas 75251

1 studies enrolling now · 13 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Clostridium Difficile Infection, Clostridium Difficile Infection (CDI), Communicable Diseases, Contraception, Diabetes, Endometriosis, Endometriosis Related Pain, Heavy Menstrual Bleeding, Infection, Overweight, PTSD

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• 12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients — Stopped early
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) — Completed
• Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD — Stopped early
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease — Completed
• Multicenter Worksite Nutrition Study — Completed